Valuation: Medpace Holdings, Inc.

Market Cap 16.81B 14.56B 13.61B 12.44B 23.43B 1,604B 23.8B 160B 62.61B 802B 63.14B 61.76B 2,672B P/E 2026 *
34.3x
P/E 2027 * 31.4x
Enterprise Value 16.01B 13.86B 12.96B 11.84B 22.32B 1,527B 22.66B 152B 59.62B 764B 60.13B 58.81B 2,545B EV / Sales 2026 *
5.61x
EV / Sales 2027 * 5.14x
Free-Float
79.98%
Yield 2026 *
-
Yield 2027 * -
1 day+1.99%
1 week+5.08%
Current month+4.39%
1 month+11.93%
3 months+42.08%
6 months+35.06%
Current year+7.26%
1 week 576.72
Extreme 576.72
603.34
1 month 514.47
Extreme 514.47
677.9
Current year 373
Extreme 373
677.9
1 year 373
Extreme 373
677.9
3 years 227.21
Extreme 227.21
677.9
5 years 126.94
Extreme 126.945
677.9
10 years 21.76
Extreme 21.76
677.9
Manager TitleAgeSince
Chief Executive Officer 69 01/07/1992
Director of Finance/CFO 51 01/08/2021
Chief Tech/Sci/R&D Officer 65 01/09/2017
Director TitleAgeSince
Chairman 69 01/07/1992
Director/Board Member 55 01/07/2016
Director/Board Member 72 01/07/2016
Date Insider Type Main position Quantity % Market Cap.
28/07/26 Sell

Chief Operating Officer

-7,500 0.0263%
28/07/26 Sell

Chief Executive Officer

-3,510 0.0123%
30/06/26 Fiscal year

Director

66 0.0002%
Change 5-day change 1-year change 3-year change Capi.($)
+1.99%+5.08%+38.70%+125.08% 16.81B
-0.22%+3.31%+6.21%+16.14% 50.03B
+0.89%+13.44%+491.34%+594.30% 44.36B
+3.08%+14.42%+24.57%+81.39% 40.82B
+1.38%+3.70%+34.54%+9.11% 39.83B
+0.85%+10.32%+21.22%+47.64% 32.51B
+0.08%+5.00% - - 16.85B
-0.63%+1.13%+5.04%+20.83% 14.05B
+3.56%+19.98%+86.23%+27.29% 13.22B
+0.94%+4.82%+4.80%-35.19% 12.81B
Average +1.19%+267.97%+79.18%+98.51% 28.13B
Weighted average by Cap. +1.14%+288.99%+102.48%+131.26%

Financials

2026 *2027 *
Net sales 2.85B 2.47B 2.31B 2.11B 3.97B 272B 4.04B 27.06B 10.62B 136B 10.71B 10.47B 453B 3.03B 2.62B 2.45B 2.24B 4.22B 289B 4.28B 28.72B 11.27B 144B 11.37B 11.12B 481B
Net income 503M 435M 407M 372M 700M 47.93B 711M 4.77B 1.87B 23.98B 1.89B 1.85B 79.86B 547M 473M 442M 404M 762M 52.13B 774M 5.19B 2.04B 26.08B 2.05B 2.01B 86.86B
Net Debt -802M -695M -649M -593M -1.12B -76.52B -1.14B -7.61B -2.99B -38.28B -3.01B -2.95B -127B -1.25B -1.08B -1.01B -926M -1.75B -119B -1.77B -11.88B -4.66B -59.75B -4.7B -4.6B -199B
Logo Medpace Holdings, Inc.
Medpace Holdings, Inc. is a scientifically driven, global, full-service clinical contract research organization (CRO) providing phase I-IV clinical development services to the biotechnology, pharmaceutical and medical device industries. The Company partners with pharmaceutical, biotechnology, and medical device companies in the development and execution of clinical trials. The Company's drug development services focus on full-service Phase I-IV clinical development services and include development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support. The Company also provides bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. The Company's operations are principally based in North America, Europe, and Asia.
Employees
6,500
Date Price Change Volume
10/08/26 $602.43 +1.99% 233,638
07/08/26 $590.67 +0.97% 136,483
06/08/26 $585.01 -0.47% 148,658
05/08/26 $587.75 +2.20% 246,169
04/08/26 $575.08 +0.31% 227,919
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
13
Last Close Price
602.43USD
Average target price
581.83USD
Spread / Average Target
-3.42%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. MEDP Stock